Advances

Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium, Showcasing Advances in Breast Cancer Risk Assessment and Treatment

Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium, Showcasing Advances in Breast Cancer Risk Assessment and Treatment

A featured discussion sheds light on how the Combined Risk Score can lead to better breast cancer prevention and screening strategies. SALT LAKE CITY, Nov. 29, 2022 (GLOBE NEWSWIRE) — Myriad Genetics, Inc.., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced several new data presentations at the San Antonio Breast Cancer …

Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium, Showcasing Advances in Breast Cancer Risk Assessment and Treatment Read More »

Comparative Timeline: The Life of Kathleen Folbigg and Advances in Genetic Research

Comparative Timeline: The Life of Kathleen Folbigg and Advances in Genetic Research

New South Wales will conduct a second inquiry into Kathleen Folbigg’s convictions. At the center of this new investigation is new data on the protein calmodulin – specifically one of its coding genes, CALM2 – and a mutated form of the gene known as G114R, which can cause heart arrhythmias in young children. In this …

Comparative Timeline: The Life of Kathleen Folbigg and Advances in Genetic Research Read More »